ENDOMETRIAL CARCINOMA (EC)
Clinical trials for ENDOMETRIAL CARCINOMA (EC) explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ATV-1601, in people with advanced solid tumors or certain breast cancers that have a specific AKT1 E17K mutation. The main goals are to check safety, find the right dose, and see how the drug moves through the body. About 134 adults w…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug TPST-1495 tested in cancer patients before surgery
Disease control OngoingThis study tests a drug called TPST-1495 in people with endometrial or colorectal cancer who are scheduled for surgery. The drug aims to help the immune system fight cancer by blocking certain signals. Researchers will check blood and tumor samples before and after treatment to s…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC